Evidence map›Paper›PMID 41555035›Full record

Trial reportNature medicine2026

An LLM chatbot to facilitate primary-to-specialist care transitions: a randomized controlled trial.

Xinge Tao, Shuya Zhou, Kai Ding, Sairan Li, Yanzeng Li, Boyou Wu, Qirui Huang, Wangyue Chen, Muzi Shen, En Meng and 7 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xinge Tao *School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID http://orcid.org/0009-0006-8548-6733
Shuya Zhou *School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Kai Ding *Department of Respiratory and Critical Care Medicine, Center of Respiratory Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.ORCID http://orcid.org/0000-0002-5559-565X
Sairan LiSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yanzeng LiInstitute of Artificial Intelligence and Future Networks, Beijing Normal University, Zhuhai, China.ORCID http://orcid.org/0000-0003-4880-5804
Boyou WuSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Qirui HuangSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Wangyue ChenSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Muzi ShenSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
En MengSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xiaowang ChenDepartment of Information Technology, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Hong HuDepartment of Endocrinology, Affiliated Hospital of Gansu Medical College, Pingliang, China.
Jinchao ZhangPattern Recognition Center, WeChat AI, Tencent Inc, Beijing, China.ORCID http://orcid.org/0000-0003-4611-9675
Jie ZhouPattern Recognition Center, WeChat AI, Tencent Inc, Beijing, China.ORCID http://orcid.org/0000-0002-5899-5165
Lei ZouWangxuan Institute of Computer Technology, Peking University, Beijing, China.
Libing MaDepartment of Respiratory and Critical Care Medicine, Center of Respiratory Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China. malibing1984@163.com.ORCID http://orcid.org/0000-0002-7234-2312
Shasha HanSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. hanshasha@pumc.edu.cn.ORCID http://orcid.org/0000-0001-7388-8125

Funding

National Natural Science Foundation of China (National Science Foundation of China) No.62532001National Natural Science Foundation of China (National Science Foundation of China) No. 82260008National Natural Science Foundation of China (National Science Foundation of China) No. 82304269
6 · The paper itself

Abstract

Patient-facing large language models (LLMs) hold potential to streamline inefficient transitions from primary to specialist care. We developed the preassessment (PreA), an LLM chatbot co-designed with local stakeholders, to perform the general medical consultations for history-taking, preliminary diagnoses, and test ordering that would normally be performed by primary care providers and to generate referral reports for specialists. PreA was tested in a randomized controlled trial involving 111 specialists from 24 medical disciplines across two health centers, where 2,069 patients (1,141 women; 928 men) were randomly assigned to use PreA independently (PreA-only), use it with staff support (PreA-human), or not use it (No-PreA) before specialist consultation. The trial met its primary end points with the PreA-only group showing significantly reduced physician consultation duration (28.7% reduction; 3.14 ± 2.25 min) compared to the No-PreA group (4.41 ± 2.77 min; P < 0.001), alongside significant improvements in physician-perceived care coordination (mean scores 113.1% increase; 3.69 ± 0.90 versus 1.73 ± 0.95; P < 0.001) and patient-reported communication ease (mean scores 16.0% increase; 3.99 ± 0.62 versus 3.44 ± 0.97; P < 0.001). Equivalent outcomes between the PreA-only and PreA-human groups confirmed the autonomous operation capability. Co-designed PreA outperformed the same model with additional fine-tuning on local dialogues across clinical decision-making domains. Co-design with local stakeholders, compared to passive local data collecting, represents a more effective strategy for deploying LLMs to strengthen health systems and enhance patient-centered care in resource-limited settings. Chinese Clinical Trial Registry identifier: ChiCTR2400094159 .

Indexed as

Primary Health CareSpecializationAdultFemaleHumansLarge Language ModelsMaleMiddle AgedReferral and Consultation

Identifiers

PMID41555035
PMCPMC13004692

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.